Neil Dahiya

Senti Biosciences Reveals $37.6 Million Capital Raise Through Oversubscribed Private Equity Offering

Senti Biosciences, Inc., a biotechnology firm currently in the clinical-stage, is advancing innovative cell and gene therapies via its unique gene circuit platform. The company has finalized a securities purchase agreement, permitting select existing and new accredited investors to purchase

Senti Biosciences Reveals $37.6 Million Capital Raise Through Oversubscribed Private Equity Offering Read More »